10X Fund, L.P. 5
5 · GALECTIN THERAPEUTICS INC · Filed Oct 10, 2025
Insider Transaction Report
Form 5
10X Fund, L.P.
10% Owner
Transactions
- Sale
Common Stock
2024-04-22$3.06/sh−21,323$65,248→ 5,925,884 total(indirect: By 10X Fund, LP) - Sale
Common Stock
2024-04-23$3.06/sh−3,677$11,252→ 5,922,207 total(indirect: By 10X Fund, LP)
Footnotes (1)
- [F1]10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.